Wilson & Boucher Capital Management’s Amgen AMGN Stock Holding History

Wilson & Boucher Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Hold	2,773	–	–	0.59%	42
2026 Q1	$976K	Hold	2,773	–	–	0.65%	41
2025 Q4	$908K	Hold	2,773	–	–	0.6%	45
2025 Q3	$783K	Sell	2,773 -300	-10%	-$87K	0.51%	53
2025 Q2	$858K	Hold	3,073	–	–	0.6%	47
2025 Q1	$957K	Hold	3,073	–	–	0.71%	40
2024 Q4	$801K	Sell	3,073 -10	-0.3%	-$2.97K	0.57%	50
2024 Q3	$993K	Hold	3,083	–	–	0.68%	42
2024 Q2	$963K	Sell	3,083 -100	-3%	-$29.4K	0.74%	41
2024 Q1	$905K	Sell	3,183 -380	-11%	-$111K	0.71%	39
2023 Q4	$1.03M	Hold	3,563	–	–	0.86%	34
2023 Q3	$958K	Buy	3,563 +8	+0.2%	+$2K	0.91%	32
2023 Q2	$789K	Hold	3,555	–	–	0.71%	45
2023 Q1	$859K	Buy	3,555 +10	+0.3%	+$2.46K	0.83%	38
2022 Q4	$931K	Hold	3,545	–	–	0.95%	34
2022 Q3	$799K	Hold	3,545	–	–	0.93%	37
2022 Q2	$862K	Sell	3,545 -200	-5%	-$49K	0.95%	39
2022 Q1	$906K	Buy	3,745 +100	+3%	+$23K	0.82%	41
2021 Q4	$820K	Buy	+3,645	New	+$769K	0.74%	47

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wilson & Boucher Capital Management's AMGN Position: Q2 2026 in Review

Wilson & Boucher Capital Management held its Amgen (AMGN) position steady in Q2 2026 at 2,773 shares worth $1M. The position accounts for 0.59% of the portfolio, ranked #42.

Wilson & Boucher Capital Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.03M in Q4 2023. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Wilson & Boucher Capital Management held 2,773 shares of Amgen worth $1M as of Q2 2026.
Wilson & Boucher Capital Management left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.59% of Wilson & Boucher Capital Management's portfolio in Q2 2026, its #42 holding.
Wilson & Boucher Capital Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
Wilson & Boucher Capital Management's Amgen position peaked at $1.03M in Q4 2023.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q2 2026, filed 19 Aug 2026.